Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

PET disease extent in EAU BCR low-risk patients, EAU BCR high-risk patients, and BCP patients (A) and predictors of PET M1 disease (B). OR = odds ratio. Image courtesy of Justin Ferdinandus, Wolfgang P. Fendler, Andrea Farolfi, et al.

News | Prostate Cancer

PSMA PET Validates EAU Classification System to Determine Risk of Prostate Cancer Recurrence

January 24, 2022 — New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk ...

January 24, 2022

NNSA’s lease contract will provide SHINE with the low-enriched uranium necessary to produce Mo-99 while DOE-EM’s contract details requirements surrounding the return of any resulting radioactive waste unable to be disposed of commercially once Mo-99 production is complete.

News | Molecular Imaging

DOE Offices and SHINE Sign First-ever Contracts Under Uranium Lease and Take-back Program to Produce Domestic Mo-99

Janaury 10, 2022 — The Department of Energy’s National Nuclear Security Administration (NNSA) and Office of ...

January 10, 2022

Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view

News | Computed Tomography (CT)

Computed Tomography (CT) Scanners Devices and Equipment Global Market Report 2021

January 3, 2022 — The "Computed Tomography (CT) Scanners Devices and Equipment Global Market Report 2021: COVID-19 ...

January 03, 2022

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announced a new contract for the installation of a Proteus ONE[1] proton therapy solution with Proton International Arkansas LLC – a joint venture formed by Proton International, the University of Arkansas for Medical Sciences (UAMS), Baptist Health, and Arkansas Children’s.

News | Proton Therapy

IBA and Proton International Sign Contract for Proteus ONE Proton Therapy Solution in Arkansas

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

January 03, 2022

Image from a co-registered PET-CT study from dual modality scanner. Patient with multiple metastatic lesions in liver & lung. PET data superimposed over CT scan axial slice through lung metastases

News | Molecular Imaging

Global Nuclear Imaging Market Report

December 29, 2021 — The global nuclear imaging devices and equipment market is expected to grow from $2.45 billion in ...

December 29, 2021

Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.

News | Radiation Therapy

Mirion Technologies to Acquire Computerized Imaging Reference Systems

December 10, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

December 10, 2021

News | Molecular Imaging

Ascelia Pharma Presents Study Showing Comparable Efficacy of Orviglance Lesion Visualization and Detection to Gadolinium

December 7, 2021 — Orviglance* is a novel manganese-based oral contrast agent for magnetic resonance imaging (MRI) ...

December 07, 2021

After the absorption of an X-ray photon, the water molecule can bend up so far that after only about ten femtoseconds (quadrillionths of a second) both hydrogen atoms (grey) are facing each other, with the oxygen atom (red) in the middle. This motion can be studied by absorbing a second X-ray photon. Credit: DESY, Ludger Inhester

News | Molecular Imaging

X-ray Laser Reveals How Radiation Damage Arises

December 7, 2021 — An international research team has used the X-ray laser European XFEL to gain new insights into how ...

December 07, 2021

CIRS specializes in the design, development and commercialization of tissue equivalent medical imaging and radiation therapy phantoms for the radiotherapy and radio-diagnostic markets.

News | Nuclear Imaging

Mirion Technologies Completes Acquisition of Computerized Imaging Reference Systems, Inc.

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

December 03, 2021

IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced a new contract in which NorthStar will purchase a third Rhodotron TT300 HE electron beam accelerator from IBA.

News | Nuclear Imaging

IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

November 22, 2021

Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and 8k monitor system for digital pathology for live tissue biopsy movies in real time. Saltus 8k imaging system monitors microscopic movies of live biological tissue specimens in real time.

News | Digital Pathology

Real-time Monitoring for Digital Pathology of Live Biological Tissue Specimens

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

November 15, 2021

News | Molecular Imaging

NorthStar Medical Radioisotopes Expansion Event Unveils Advanced Radioisotope Production Equipment and Breaks Ground on First-in-Kind Therapeutic Radioisotope Production Facility

October 29, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

October 29, 2021

RAD Technology Medical Systems provides complex, design-built modular facilities for the healthcare industry. #ASTRO #ASTRO21

News | Radiation Therapy

RAD Technology Medical Systems to Exhibit at the ASTRO 2021

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

October 19, 2021

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced presentations on Axumin (fluciclovine F 18) and 18F-fluciclovine at the upcoming American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

News | PET Imaging

Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and 18F-Fluciclovine at ASTRO21

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

October 19, 2021

(A) CT (B) PET and (C) fused PET/CT of 68Ga-Ga-PSMA-11 PET scan of a patient with distant osseous metastases in the right proximal femur, visible on PET with intermediate PSMA uptake (SUVmax = 7.8) and missed by CT, confirmed later on follow-up CT imaging.

News | PET Imaging

PSMA PET Imaging More Accurate than CT in Detecting Hepatocellular Carcinoma

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

October 18, 2021

NBTXR3 is a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy.

News | Radiation Therapy

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program at ASTRO21

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

October 07, 2021

Cardiac coronary computed tomography angiography (CCTA) exam showing different views of the myocardium and the coronary arteries. This was scanned on a Canon Aquilion Prime CT scanner.

Feature | Cardiac Imaging

Trends in Cardiac Imaging Over Past Decade Show Rapid Rise in CT

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

October 06, 2021

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

News | Magnetic Resonance Imaging (MRI)

Modern Simulations Could Improve MRIs

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

September 20, 2021

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.

News | Radiation Oncology

IBA and SCK CEN Join Forces to Enable Production of Actinium-225

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

September 17, 2021

Bicameral legislation in U.S. House and Senate designed to address equity issues in patient access and affordability for innovative diagnostic radiopharmaceuticals

News | Radiopharmaceuticals and Tracers

Blue Earth Diagnostics Supports Timely Consideration and Passage of the FIND Act of 2021 by U.S. Congress

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

September 17, 2021